Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)

Cedars-Sinai Department of Neurology, Los Angeles, California, United States

University of California San Francisco, San Francisco, California, United States

Parkinson's Disease and Movement Disorders Center, Boca Raton, Florida, United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Ichan School of Medicine at Mount Sinai/Beth Israel Downtown-Movement Disorder Center, New York, New York, United States

Evergreen Health Laboratory, Kirkland, Washington, United States

Inland Northwest Research, Spokane, Washington, United States

Technische Universität Dresden, Dresden, Germany

University of Lübeck, Lübeck, Germany

University Hospital Tübingen, Tübingen, Germany

Rabin Medical Center, Petah Tikva, Israel

Movement Disorders Institute, Sheba Medical Center, Ramat Gan, Israel

Tel Aviv Medical Center, Tel Aviv, Israel

Hospital Clinic de Barcelona, Barcelona, Spain

Hospital Universitari General de Catalunya, Barcelona, Spain

Hospital Universitari Vall d'Hebron, Barcelona, Spain

Hospital Universitario Donostia, Donostia / San Sebastian, Spain

Universitary Hospital La Princesa, Madrid, Spain

IDIVAL/University Hospital Marques de Valdecilla, Santander, Spain

Hospital Universitario Virgen del Rocio, Seville, Spain